Synergistic activity of the CDK4/6 antagonist narazaciclib (ON123300) with irreversible BTK inhibition in ibrutinib-resistant mantle cell lymphoma

被引：0
|
作者：
Profitos-Peleja, Nuria
Ribeiro, Marcelo L.
Silverstein, Adar Makovski
Cosenza, Stephen
Roue, Gael
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5974
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5974
引用
收藏
页数：2
相关论文
共 49 条
  • [1] Narazaciclib, a Differentiated CDK4/6 Antagonist, Prolongs Cell Cycle Arrest and Metabolomic Reprogramming, Enabling Restoration of Ibrutinib Sensitivity in BtkiResistant Mantle Cell Lymphoma
    Profitos-Peleja, Nuria
    Lima Ribeiro, Marcelo
    Parra, Jeronimo
    Fernandez-Serrano, Miranda
    Marin-Escudero, Pau
    Josep Bech, Joan
    De La Torre, Carolina
    Silverstein, Adar Makovski
    Cosenza, Steve
    Fruchtman, Steven M.
    Esteller, Manel
    Roue, Gael
    BLOOD, 2023, 142
  • [2] Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas
    S K A Divakar
    M V Ramana Reddy
    S C Cosenza
    S J Baker
    D Perumal
    A C Antonelli
    J Brody
    B Akula
    S Parekh
    E Premkumar Reddy
    Leukemia, 2016, 30 : 86 - 93
  • [3] Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas
    Divakar, S. K. A.
    Reddy, M. V. Ramana
    Cosenza, S. C.
    Baker, S. J.
    Perumal, D.
    Antonelli, A. C.
    Brody, J.
    Akula, B.
    Parekh, S.
    Reddy, E. Premkumar
    LEUKEMIA, 2016, 30 (01) : 86 - 93
  • [4] Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib
    Sun, Baohua
    Shah, Bhavin
    Fiskus, Warren
    Qi, Jun
    Rajapakshe, Kimal
    Coarfa, Cristian
    Li, Li
    Devaraj, Santhana G. T.
    Sharma, Sunil
    Zhang, Liang
    Wang, Michael L.
    Saenz, Dyana T.
    Krieger, Stephanie
    Bradner, James E.
    Bhalla, Kapil N.
    BLOOD, 2015, 126 (13) : 1565 - 1574
  • [5] HX301 (ON123300) shows broad antitumor activity in preclinical mantle cell lymphoma models, inclusive of those resistant to BTKi
    Jiao, Z.
    Ke, H.
    Zhang, F.
    Li, H.
    Wang, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S18 - S18
  • [6] Molecular Targeting and Inactivation of Glutaminase and CDK4/6 in Mantle Cell Lymphoma
    Gibbs, Bettine E.
    Masamha, Chioniso P.
    FASEB JOURNAL, 2018, 32 (01):
  • [7] Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
    Leonard, John P.
    LaCasce, Ann S.
    Smith, Mitchell R.
    Noy, Ariela
    Chirieac, Lucian R.
    Rodig, Scott J.
    Yu, Jian Q.
    Vallabhajosula, Shankar
    Schoder, Heiko
    English, Patricia
    Neuberg, Donna S.
    Martin, Peter
    Millenson, Michael M.
    Ely, Scott A.
    Courtney, Rachel
    Shaik, Naveed
    Wilner, Keith D.
    Randolph, Sophia
    Van den Abbeele, Annick D.
    Chen-Kiang, Selina Y.
    Yap, Jeffrey T.
    Shapiro, Geoffrey I.
    BLOOD, 2012, 119 (20) : 4597 - 4607
  • [8] TG-1701, a novel irreversible Bruton's kinase (BTK) inhibitor, cooperates with ublituximab-driven ADCC and ADCP in in vitro and in vivo models of ibrutinib-resistant mantle cell lymphoma
    Ribeiro, Marcelo L.
    Reyes-Garau, Diana
    Vinyoles, Meritxell
    Armengol, Marc
    Miskin, Hari
    Bosch, Francesc
    Menendez, Pablo
    Normant, Emmanuel
    Roue, Gael
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Combined Inhibition of CDK2 and CL2 Overrides Resistance to Targeting BTK and CDK 4/6 in Mantle Cell Lymphoma Therapy
    Al-Ansari, Haya Y.
    Bashir, Saira
    Cui, Adrienne
    Huang, Xiangao
    Hu, Yang
    Martin, Peter
    Elemento, Olivier
    Di Liberto, Maurizio
    Chen-Kiang, Selina
    BLOOD, 2022, 140
  • [10] Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma
    Di Liberto, Maurizio
    Hu, Yang
    Huang, Xiangao
    Inghirami, Giorgio
    Wang, Kevin
    Lee, Christina Y.
    Maddocks, Kami J.
    Blum, Kristie A.
    Ruan, Jia
    Leonard, John P.
    Bartlett, Nancy L.
    Martin, Peter
    Elemento, Olivier
    Chen-Kiang, Selina
    BLOOD, 2024, 144 : 831 - 832
12345